Search Results 1-10 of 16652 for Proto-oncogene
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.
10 issue of Cancer Cell the discovery of two oncogenes that work together to sustain a population of cells in lung squamous cell carcinoma, which may be ...
“We discovered that in these particular cases, the cancer exhibited a MET oncogene amplification, which creates a hostile environment for immunotherapy,” says ...
Interpret technology — immunostains, RET proto-oncogene, DNA ploidy, reverse transcription-polymerase chain reaction (RT-PCR), gene profiling and implications ...
... proto-oncogene (RET) rearrangement/fusion, or one not listed following approval by the study chair prior to registration. Patients must have measurable ...
Bidirectional sequence analysis was performed to test for the presence of a mutation in exons 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene and was ...
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood ... Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate ...
The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic ...
While PKD1 mediates cell proliferation and also acts as a suppressor of breast tumor cell invasion, PKD3, when expressed, mediates all oncogenic functions.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.